Produkty 2143952-36-5

CAS 2143952-36-5 występuje w naszej ofercie pod nazwami: SH–42, SH-42/ 99%, SH-42, 99%, 99%, SH-42, 99.87%. Oferty producentów: GLPBio, TargetMol, Chemat, MedChemExpress. Dostępne opakowania: 5mg, 2mg, 1mg, 10mg, 25mg, 25 mg, 100 mg, 50 mg.

SH–42
GLPBio
  • opakowanie: 5mg, 1mg, 10mg, 25mg
  • Warianty: 4
od 615,76
Zobacz produkt
SH-42/ 99%
TargetMol
  • opakowanie: 2mg
  • Warianty: 1
od 1548,31
Zobacz produkt
SH-42, 99%, 99%
Chemat
  • opakowanie: 1mg, 2mg, 5mg, 10mg
  • Warianty: 5
od 928,40
Zobacz produkt
SH-42, 99.87%
MedChemExpress
  • opakowanie: 25 mg, 100 mg, 50 mg, 10 mg
  • Warianty: 5
od 839,82
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(3S,5S,9R,10S,13R,14R,17R)-17-[(2S)-1-formyloxypropan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate (CAS 2143952-36-5) to związek chemiczny o wzorze sumarycznym C25H38O4 i masie molowej 402.6 g/mol. Nazwa systematyczna IUPAC: [(3S,5S,9R,10S,13R,14R,17R)-17-[(2S)-1-formyloxypropan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate. InChIKey: ZMSGAXSBKXUQKY-PUCUFLQQSA-N.

Dane identyfikacyjne
Wzór sumarycznyC25H38O4
Masa molowa402.6 g/mol
Nazwa IUPAC[(3S,5S,9R,10S,13R,14R,17R)-17-[(2S)-1-formyloxypropan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
InChIKeyZMSGAXSBKXUQKY-PUCUFLQQSA-N
SMILESC[C@H](COC=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC[C@@H]4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: orb1693645
Izomery (ten sam wzór sumaryczny)
(1R,3S,4R,7S,8E,11R,12S)-4,12-dihydroxy-1,4-dimethyl-12-[(2S)-6-methylhept-5-en-2-yl]-6-oxotricyclo[9.3.0.03,7]tetradec-8-ene-8-carbaldehyde C25H38O4
methyl 4-(10,13-dimethyl-3,7-dioxo-2,4,5,6,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate C25H38O4
methyl (4R)-4-[(3R,5R,8S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-12-oxo-1,2,3,4,5,6,7,8,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoate C25H38O4
2,3-dihydroxypropyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate C25H38O4
methyl (4R)-4-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7-dioxo-2,4,5,6,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate C25H38O4
(8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-(2-methyl-1,3-dioxolan-2-yl)spiro[1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,2'-1,3-dioxolane] C25H38O4
(1R,3Z,5S,8Z,12Z,15S)-5,17-dihydroxy-18-[(2S)-1-hydroxypropan-2-yl]-4,8,12,15-tetramethylbicyclo[13.3.0]octadeca-3,8,12,17-tetraen-16-one C25H38O4
(E)-5-[(1R,2R,4R,4aR,8aS)-1,2,4a,5-tetramethyl-4-[(E)-2-methylbut-2-enoyl]oxy-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid C25H38O4
[(3S,8R,9S,10R,13S,14S,17S)-10,13-dimethyl-17-propanoyloxy-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] propanoate C25H38O4
(2S,3S,4E,6E)-7-[(1R,2S,4R,5R,6S,7S,9S,11R)-5-[(E)-but-2-en-2-yl]-4,11-dimethyl-3,10-dioxatetracyclo[5.5.0.02,4.09,11]dodecan-6-yl]-2,4-dimethylhepta-4,6-diene-1,3-diol C25H38O4
6-[[(3S,8S,9S,10R,13S,14S)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-oxohexanoic acid C25H38O4